Immunotherapy Press Release

Title Picture
06/18/2018 - 16:24
New asthma tool determines best treatment for severe asthma patients
American College of Chest Physicians's picture
American Colleg...
06/18/2018 - 15:09
Data presented at EHA shows significantly improved overall survival compared to historical data
Biolinerx's picture
Biolinerx
06/18/2018 - 08:20
Computerworld Names Cancer Treatment Centers of America to 2018 List of 100 Best Places to Work in IT
Cancer Treatment Centers of America's picture
Cancer Treatmen...
06/13/2018 - 16:08
Older Melanoma Patients May Respond to Anti-PD1 Immunotherapy Better Than Younger Patients
American Association for Cancer Research's picture
American Associ...
06/13/2018 - 10:05
Older Melanoma Patients Have Better Response to Immune Checkpoint Blockade Therapy
Wistar Institute's picture
Wistar Institute
06/13/2018 - 09:25
BioLineRx to Participate at JMP Securities 2018 Life Sciences Conference
Biolinerx's picture
Biolinerx
06/12/2018 - 11:47
Agilent Companion Diagnostic Gains Expanded FDA Approval in Cervical Cancer
Agilent's picture
Agilent
06/11/2018 - 21:26
Cellectis Publishes Novel Methods to Improve the Clinical Use of Chimeric Antigen Receptor T-Cell Therapy in Scientific Reports
Cellectis's picture
Cellectis
06/11/2018 - 20:55
Cancer Research UK tests first of its kind vaccine to treat lung cancer
Cancer Research UK's picture
Cancer Research UK
06/10/2018 - 23:23
Gene scissors may increase cancer risk
University of Helsinki's picture
HelsinkiUniv
06/10/2018 - 20:34
Genome-editing tool could increase cancer risk
Karolinska Institutet's picture
KarolinskaInstitutet
06/08/2018 - 06:14
U.S. PATENT OFFICE ALLOWS NEW CEL-SCI PATENTS FOR LEAPS VACCINE PLATFORM TECHNOLOGY
Cel-Sci's picture
Cel-Sci
06/07/2018 - 19:52
Surgical Oncologist Dr. Steven Rosenberg Receives the 2018 Jacobson Innovation Award
American College of Surgeons's picture
American Colleg...
06/07/2018 - 12:45
GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs
General Electric's picture
General Electric
06/07/2018 - 09:28
U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation
Pfizer's picture
Pfizer
06/07/2018 - 09:07
St. Jude partners with nations top cancer centers to endorse goal of eliminating HPV-related cancers in the United States
St Jude's picture
St Jude
06/07/2018 - 08:24
Immunotherapy is the way to go with future cancer treatment
University of Helsinki's picture
HelsinkiUniv
06/04/2018 - 22:55
Personalized vaccine may increase long-term survival in people with deadliest form of brain cancer
University of California Los Angeles's picture
UCLA
06/04/2018 - 20:37
BWF Invests $9.1 Million in the Careers of Physician-Scientists
Burroughs Wellcome Fund's picture
BW Fund
06/04/2018 - 13:57
James Allison, Ph.D., Wins 2018 Dr. Paul Janssen Award for Biomedical Research
Johnson and Johnson's picture
Johnson and Johnson
06/04/2018 - 11:45
New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments
National Institutes of Health's picture
NIH
06/04/2018 - 10:56
Researchers discover how colon cancer mutates to escape the immune system
University of California Los Angeles's picture
UCLA
06/04/2018 - 09:10
Rexahn Pharmaceuticals Announces Presentations at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Rexahn Pharmaceuticals's picture
Rexahn Pharmace...
06/02/2018 - 12:36
Phase III IMpower131 study showed Tecentriq(atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death for people with advanced squamous non-small cell lung cancer
Rocheusa's picture
Rocheusa
06/02/2018 - 12:17
Phase III IMpower131 Study Showed Genentechs TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin And ABRAXANE) Reduced the Risk of Disease Worsening or Death for People With Advanced Squamous Non-Small Cell Lung Cancer
Genentech's picture
Genentech
06/02/2018 - 07:08
Celldex Presents Promising Data from Phase 1/2 Study of Varlilumab and Opdivo at 2018 ASCO Annual Meeting
Celldex's picture
Celldex
06/01/2018 - 11:30
Pediatric cancer research highlighted at ASCO Annual Meeting
St Jude's picture
St Jude
06/01/2018 - 09:12
Differences in the Immune Cell Environment Help Explain Racial Disparities in Breast Cancer
Roswell Park Cancer Institute's picture
Roswell Park Ca...
06/01/2018 - 08:49
New Treatment Combination Improves Outcomes for Some Patients with Colorectal Cancer
Roswell Park Cancer Institute's picture
Roswell Park Ca...
05/31/2018 - 13:03
Daiichi Sankyo Initiates Phase 2 Study of DS-8201 in Patients with Advanced HER2-Overexpressing or HER2-Mutated Non-Squamous Non-Small Cell Lung Cancer
Daiichi Sankyo's picture
Daiichi Sankyo
05/31/2018 - 10:40
How Might Baking Soda Boost Cancer Therapy?
Wistar Institute's picture
Wistar Institute
05/30/2018 - 13:08
Trial to test new treatment combination for children and adults with leukaemia
Cancer Research UK's picture
Cancer Research UK
05/30/2018 - 11:31
Dana-Farber researchers present findings at ASCO annual meeting
Dana Farber's picture
Dana Farber
05/29/2018 - 13:10
Phase III IMpower130 study showed Roches Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane) helped people with metastatic non-squamous NSCLC live significantly longer compared to chemotherapy alone
Rocheusa's picture
Rocheusa
05/29/2018 - 10:39
Immunotherapy Clinical Trial Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study
Atlantic Health System's picture
Atlantic Health...
05/28/2018 - 07:32
Phase III IMpower130 Study Showed Genentechs TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped People With Metastatic Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy Alone
Genentech's picture
Genentech
05/24/2018 - 08:38
CORNET Award in Drug Discovery and Development goes to project targeting novel treatments in anti-tumor immunity
Southern Research's picture
Southern Research
05/23/2018 - 12:55
Two Roswell Park Immunology Leaders Honored by Society for Thermal Medicine
Roswell Park Cancer Institute's picture
Roswell Park Ca...
05/23/2018 - 07:35
The American Association for Cancer Research Applauds Passage of the Childhood Cancer STAR Act
American Association for Cancer Research's picture
American Associ...
05/23/2018 - 06:32
Dana-Farber Medical Oncology Chair named Howard Hughes Medical Institute Investigator
Dana Farber's picture
Dana Farber
05/22/2018 - 12:18
Approval of UCART123 Amendment in AML to Accelerate Clinical Development
Cellectis's picture
Cellectis
05/22/2018 - 05:13
CEL-SCI CORPORATION TO PRESENT AT THE 8TH ANNUAL LD MICRO INVITATIONAL
Cel-Sci's picture
Cel-Sci
05/21/2018 - 19:13
CureWorks Collaborative Launches to Accelerate Development of Immunotherapy Treatments for Childhood Cancers, Increase Access to Clinical Trials
Seattle Children's's picture
Seattle Children's
05/21/2018 - 12:35
Seattle Children's Opens Immunotherapy Trial For Children With Relapsed Central Nervous System Tumors That Delivers CAR T Cells Directly Into the Brain
Seattle Children's's picture
Seattle Children's
05/17/2018 - 13:00
BioLineRx to Present Overall Survival Data at EHA from Phase 2a Study of BL-8040 in r/r AML Patients
Biolinerx's picture
Biolinerx
05/17/2018 - 12:19
BioLineRx Reports Results of Phase 2 Study for BL-8040 Monotherapy in Stem Cell Mobilization for Allogeneic Bone Marrow Transplantation
Biolinerx's picture
Biolinerx
05/17/2018 - 08:15
ASCO 2018 Preview: Precision Medicine, CAR T Cells and Immunomodulators
Celgene's picture
Celgene
05/16/2018 - 13:47
Celldex Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Celldex's picture
Celldex
05/16/2018 - 13:25
Cancer Treatment Centers of America Celebrates Cancer Survivors at Interactive Event in Chicago
Cancer Treatment Centers of America's picture
Cancer Treatmen...
05/16/2018 - 06:46
BioLineRx Announces Grant of European Patent Covering Use of BL-8040 with Cytarabine for Treating Acute Myeloid Leukemia
Biolinerx's picture
Biolinerx
05/15/2018 - 20:04
Multiple Myeloma Research Foundation (MMRF) Awards Grants to Young Researchers To Advance Understanding of Myeloma Disease Biology and Drive Precision Medicine
Multiple Myeloma Research Foundation's picture
MMRF
05/10/2018 - 14:32
Cellectis to Present Data at the 2018 ASGCT Annual Meeting
Cellectis's picture
Cellectis
05/10/2018 - 14:25
Scientists present research at latest meeting of Arizona Wellbeing Commons
Biodesign Institute's picture
Biodesign Institute
05/10/2018 - 06:47
New Grants Totaling $2.6 Million Fund Work to Reduce Immunotherapy Side Effects
American Cancer Society's picture
American Cancer...
05/10/2018 - 02:35
Roche provides update on Phase III study of Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people with heavily pre-treated locally advanced or metastatic colorectal cancer
Rocheusa's picture
Rocheusa
05/09/2018 - 23:41
New cancer immunotherapy drugs rapidly reach patients after approval
Yale University's picture
YaleUniversity
05/08/2018 - 22:47
Genentech Provides Update on Phase III Study Of TECENTRIQ (Atezolizumab) and COTELLIC (Cobimetinib) in People With Heavily Pre-Treated Locally Advanced or Metastatic Colorectal Cancer
Genentech's picture
Genentech
05/08/2018 - 01:36
Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Rocheusa's picture
Rocheusa
05/07/2018 - 06:51
Roswell Park Research Identifies Link Between Ovarian and Testicular Cancer
Roswell Park Cancer Institute's picture
Roswell Park Ca...
05/06/2018 - 22:43
FDA grants priority review to Roches cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer
Rocheusa's picture
Rocheusa